Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 2 | 1 | 2 | — | — | 4 |
Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 1 | — | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 19 | 2 | — | — | — | 20 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 5 | 1 | — | — | — | 6 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 4 | — | — | — | 6 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 4 | 1 | — | — | — | 5 |
Hodgkin disease | D006689 | — | C81 | 3 | 2 | — | — | — | 5 |
Prostatic neoplasms | D011471 | — | C61 | 2 | 2 | — | — | — | 4 |
Leukemia | D007938 | — | C95 | 3 | 1 | — | — | — | 4 |
Melanoma | D008545 | — | — | 1 | 3 | — | — | — | 4 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 2 | — | — | — | 3 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 8 | — | — | — | — | 8 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 8 | — | — | — | — | 8 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 5 | — | — | — | — | 5 |
Follicular lymphoma | D008224 | — | C82 | 5 | — | — | — | — | 5 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 5 | — | — | — | — | 5 |
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | — | — | — | — | 4 |
Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 4 | — | — | — | — | 4 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | — | — | — | — | 4 |
Burkitt lymphoma | D002051 | — | C83.7 | 4 | — | — | — | — | 4 |
Large-cell lymphoma immunoblastic | D016400 | — | — | 4 | — | — | — | — | 4 |
Drug common name | Tanespimycin |
INN | tanespimycin |
Description | Tanespimycin (17-N-allylamino-17-demethoxygeldanamycin, 17-AAG) is a derivative of the antibiotic geldanamycin that is being studied in the treatment of cancer, specifically in younger patients with certain types of leukemia or solid tumors, especially kidney tumors.
|
Classification | Small molecule |
Drug class | antibiotics (Streptomyces strain) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O |
PDB | — |
CAS-ID | 75747-14-7 |
RxCUI | — |
ChEMBL ID | CHEMBL109480 |
ChEBI ID | 64153 |
PubChem CID | 6440175 |
DrugBank | — |
UNII ID | 4GY0AVT3L4 (ChemIDplus, GSRS) |